| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9005264 | Clinical Therapeutics | 2005 | 15 Pages |
Abstract
All components of the glucose triad (ie,FPG, HbA1c, and PPG) should be considered in the management of type 2 diabetes. Therapy targeted at PPG has been shown to improve glucose control and to reduce the progression of atherosclerosis and CV events; therefore, physicians should consider monitoring and targeting PPG, as well as HbAlc and FPG, in patients with type 2 diabetes.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Lawrence A. (MD), Antonio (MD), Jaime A. (MD), Markolf (MD), Louis (MD), David R. (MD), Naoko (MD), Jaakko (MD), InternationalPrandial Glucose Regulation (PGR) Study Group InternationalPrandial Glucose Regulation (PGR) Study Group,